Song Liu
- Cancer Research top 5%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 12
- Viral-associated cancers and disorders 8
- Molecular Biology top 10%
-
- Gastric Cancer Management and Outcomes 11
- Cerebrovascular and Carotid Artery Diseases 8
- Prostate Cancer Treatment and Research 7
- Biological Psychiatry top 10%
-
- Hepatocellular Carcinoma Treatment and Prognosis 9
-
- Radiomics and Machine Learning in Medical Imaging 8
- MRI in cancer diagnosis 7
Song Liu
162 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 153
- Cancer Research 401
- Oncology 478
- Molecular Biology 1.2k
- Pulmonary and Respiratory Medicine 515
- Biological Psychiatry 33
Countries citing papers authored by Song Liu
This map shows the geographic impact of Song Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Song Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Song Liu more than expected).
Fields of papers citing papers by Song Liu
This network shows the impact of papers produced by Song Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Song Liu. The network helps show where Song Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Song Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 7 | |
| 14 | 2019 | 24 | |
| 15 | Effect of high dietary fiber low glycemic index diet on intestinal flora, blood glucose and inflammatory response in T2DM patients | 2017 | 4 |
| 16 | 2017 | 1 | |
| 17 | 2016 | 23 | |
| 18 | 2016 | 19 | |
| 19 | 2011 | 35 | |
| 20 | 2010 | 2 |
About Song Liu
Song Liu is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 173 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Gastric Cancer Management and Outcomes (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Radiomics and Machine Learning in Medical Imaging (8 papers), Cerebrovascular and Carotid Artery Diseases (8 papers), Viral-associated cancers and disorders (8 papers), MRI in cancer diagnosis (7 papers) and Prostate Cancer Treatment and Research (7 papers). The work is most often cited by research in Cancer Research (401 citations), Oncology (478 citations) and Molecular Biology (1.2k citations). Song Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yaoqi Zhou, Chi Zhang, Qiang Hu, Zhen Wang, Shide Liang, Jeffrey M. Conroy, Hannelore V. Heemers, Wei Chen, Yingze Zhang and Tong Li. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.